| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | SCHEDULE 13G | Aug 15, 2022 | |
| SC 13G/A | Report | AMENDMENT TO SC 13G | Feb 14, 2022 | |
| SC 13G/A | Report | TMBR 13G/A | Feb 4, 2022 | |
| SC 13G/A | Report | TIMBER PHARMACEUTICALS, INC. | Jan 18, 2022 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC13G | Feb 16, 2021 | |
| SC 13G | Report | TMBR 13G | Feb 11, 2021 | |
| SC 13G/A | Report | TIMBER PHARMACEUTICALS, INC. | Jan 28, 2021 | |
| SC 13G | Report | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | May 29, 2020 | |
| SC 13G | Report | TIMBER PHARMACEUTICALS, INC. | May 27, 2020 | |
| SC 13G/A | Report | AMENDMENT NO. 4 TO SCHEDULE 13G | Feb 13, 2020 | |
| SC 13G/A | Report | BIOPHARMX CORPORATION | Jan 15, 2020 | |
| SC 13G/A | Report | AMENDMENT TO SCHEDULE 13G | Jun 27, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 14, 2019 | |
| SC 13G/A | Report | BIOPHARMX CORPORATION | Jan 29, 2019 | |
| SC 13G/A | Report | Feb 14, 2018 | ||
| SC 13G/A | Report | SC 13G/A | Feb 12, 2018 | |
| SC 13G/A | Report | EMPERY ASSET MANAGEMENT, LP | Jan 16, 2018 | |
| SC 13G | Report | Nov 30, 2017 | ||
| SC 13G | Report | BIOPHARMX CORPORATION | May 1, 2017 | |
| SC 13G/A | Report | Feb 13, 2017 | ||
| SC 13G/A | Report | EMPERY ASSET MANAGEMENT, LP | Jan 31, 2017 | |
| SC 13G | Report | SC 13G | Dec 2, 2016 | |
| SC 13G | Report | EMPERY ASSET MANAGEMENT, LP | Nov 30, 2016 | |
| SC 13G/A | Report | Feb 17, 2016 | ||
| SC 13G/A | Report | Feb 16, 2016 | ||
| SC 13G | Report | Apr 21, 2015 |